Evaluation of Dexamethasone Added to the Usual Infiltration With Bupivacaine in Inguinal Hernia Repair Mesh

• Status: Completed
• Trial end date: 2017-06-29
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the impact on the postoperative pain of the dexamethasone addition to the usual treatment with bupivacaine in the local infiltration of the surgical area in Inguinal Hernia Repair Mesh

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Diego Hernan Giunta, MD; SEBASTIAN ROCHE
• Collaborators: Claudio Brandi, MD; Santiago Bertone, MD; Sebastián Roche, MD
• Treatments: BB 1101; Bupivacaine; Dexamethasone; Dexamethasone acetate; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

1. Patients older than 18 years.

2. Unilateral inguinal hernioplasty.

3. That the surgery is performed in the Ambulatory Surgery Unit (UCA).

Exclusion Criteria:

1. Recurrent hernia.

2. allergies, ongoing infections, diabetes.

3. Background of rejection of prosthetic material (mesh).